Referral for Inguinal Lymph Node Evaluation and Biopsy
Refer patients with abnormally enlarged inguinal lymph nodes to interventional radiology for ultrasound-guided fine-needle aspiration cytology (FNAC) as the first-line diagnostic approach. 1
Primary Referral Pathway
For Initial Tissue Diagnosis
- Interventional radiology is the primary specialty for performing ultrasound-guided FNAC of inguinal lymph nodes, as this is the preferred diagnostic approach recommended by multiple guidelines 1
- Surgeons with specific training in FNAC techniques can also perform this procedure 1
- FNAC should be performed for all palpable inguinal nodes <4 cm to distinguish between inflammatory (30-50% of cases) and metastatic disease 2, 3
When FNAC is Negative but Suspicion Remains High
- Refer to surgical oncology for excisional biopsy if FNAC is negative but clinical suspicion persists 2, 3
- A negative FNAC must be confirmed with either excisional biopsy or careful surveillance, as false-negatives occur 2
Specialty-Specific Referral Considerations
For Suspected Penile Cancer
- Urologic oncology should be consulted early if penile lesions are present, as they will ultimately manage both the primary tumor and coordinate lymph node dissection if metastases are confirmed 2
- For high-risk primary lesions (T1G3 or worse), consider omitting FNAC and proceeding directly to inguinal lymph node dissection to avoid treatment delays 2
For Suspected Vulvar Cancer
- Gynecologic oncology is the appropriate referral for vulvar malignancies with inguinal lymphadenopathy 2
- Surgical staging with inguinofemoral lymphadenectomy or sentinel lymph node biopsy is performed by gynecologic oncologists 2
For Dynamic Sentinel Node Biopsy (DSNB)
- Surgical oncology or specialized centers with expertise in lymphoscintigraphy and blue dye localization should perform DSNB when available 2, 1
- DSNB is indicated for intermediate or high-risk disease with clinically non-palpable nodes (cN0) 2
- The technique has a 97% identification rate and 7% false-negative rate when performed by experienced teams 2
Clinical Decision Algorithm
Step 1: Initial Assessment
- Document node size, mobility, unilateral vs bilateral presentation, and relationship to surrounding structures 3
- Obtain ultrasound if nodes are non-palpable but patient has risk factors 1
Step 2: Tissue Diagnosis
- Nodes <4 cm and palpable: Refer to interventional radiology for ultrasound-guided FNAC 2, 1
- Nodes ≥4 cm or fixed: Refer to interventional radiology for FNAC, then surgical oncology for definitive management 2
- Non-palpable nodes in high-risk patients: Refer for DSNB if available, or ultrasound-guided FNAC if DSNB unavailable 2, 1
Step 3: If FNAC is Negative
- Repeat biopsy or proceed to excisional biopsy via surgical oncology referral 2, 3
- Consider surveillance only if patient is reliable and clinical suspicion is low 3
Step 4: If FNAC is Positive
- Immediate referral to surgical oncology (urologic or gynecologic depending on primary site) for inguinal lymph node dissection 2, 3
- Imaging with CT or MRI to assess for pelvic lymph node involvement 2
Critical Pitfalls to Avoid
- Do not assume all palpable inguinal nodes are malignant: 30-50% are inflammatory at initial presentation 2, 3
- Do not proceed directly to surgical excision without FNAC: This leads to unnecessary morbidity in inflammatory cases 3
- Do not delay lymphadenectomy in high-risk primary tumors: For T1G3 or worse penile lesions, proceed directly to surgical oncology rather than waiting for FNAC results 2
- Do not rely solely on CT or MRI for non-palpable nodes: These have low sensitivity (36% for CT) and should not replace tissue diagnosis 2
- Do not accept a single negative FNAC in clinically suspicious nodes: Confirm with excisional biopsy 2, 3
Special Circumstances
When DSNB is Not Available
- Ultrasound-guided FNAC becomes the primary diagnostic modality 2, 1
- Consider risk stratification using nomograms to guide surveillance vs prophylactic lymph node dissection 4